FindTrial
Sign In

Minimum effective volume of ropivacaine for ultrasound-guided brachial plexus block in children

Minimum effective volume of ropivacaine for ultrasound-guided brachial plexus block in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044656
Enrollment
Unknown
Registered
2021-03-25
Start date
2021-03-22
Completion date
Unknown
Last updated
2021-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimum effective volume of ropivacaine for axillary brachial plexus block in children

Interventions

experimental group:Axillary brachial plexus block with a predetermined dose of ropivacaine

Sponsors

Shengjing hospital of China medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 14 Years

Inclusion criteria

Inclusion criteria: ASA grade I - II, aged 0-14 years. Pediatric patients undergoing surgery beyond the elbow.

Exclusion criteria

Exclusion criteria: Coagulation abnormalities, diabetes, dementia, anticoagulation therapy, previous local anesthetic allergy, preoperative nerve injury, puncture site infection, hematoma.

Design outcomes

Primary

MeasureTime frame
pain;—

Countries

China

Contacts

Public ContactChen Liang

Shengjing hospital of China medical university

chenl_sj@126.com+86 18940258435

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026